Sorafenib With or Without Transarterial Chemoembolization (TACE) in Advanced Hepatocellular Carcinoma : A Multicenter, Randomized, Controlled Trial
Latest Information Update: 30 Aug 2024
At a glance
- Drugs Sorafenib (Primary) ; Doxorubicin; Ethiodized oil; Polyvinyl alcohol
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms SELECT
- 23 Jul 2024 Phase has been changed from 2/3 to 3.
- 23 Jul 2024 Status changed from recruiting to completed.
- 31 Jul 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.